医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
7期
477-477
,共1页
急性心肌梗死%尿激酶%静脉溶栓
急性心肌梗死%尿激酶%靜脈溶栓
급성심기경사%뇨격매%정맥용전
Acute myocardial infarction%Urokinase%Intravenous thrombolysis
目的分析评价尿激酶静脉溶栓治疗心肌梗死的临床疗效及安全性。方法对62例急性心肌梗死且符合溶栓条件的患者进行溶栓以及规范化治疗。结果发病6 h溶栓31例，28例溶解，3例未通；发病6~24 h溶栓31例，25例溶解，6例未通；再通者中2例因并发症死亡，未溶解病例中死亡3例。结论尿激酶静脉溶栓治疗安全、有效，价格便宜，早期规范的溶栓治疗是治疗 AMI的关键，适合临床推广。
目的分析評價尿激酶靜脈溶栓治療心肌梗死的臨床療效及安全性。方法對62例急性心肌梗死且符閤溶栓條件的患者進行溶栓以及規範化治療。結果髮病6 h溶栓31例，28例溶解，3例未通；髮病6~24 h溶栓31例，25例溶解，6例未通；再通者中2例因併髮癥死亡，未溶解病例中死亡3例。結論尿激酶靜脈溶栓治療安全、有效，價格便宜，早期規範的溶栓治療是治療 AMI的關鍵，適閤臨床推廣。
목적분석평개뇨격매정맥용전치료심기경사적림상료효급안전성。방법대62례급성심기경사차부합용전조건적환자진행용전이급규범화치료。결과발병6 h용전31례，28례용해，3례미통；발병6~24 h용전31례，25례용해，6례미통；재통자중2례인병발증사망，미용해병례중사망3례。결론뇨격매정맥용전치료안전、유효，개격편의，조기규범적용전치료시치료 AMI적관건，괄합림상추엄。
Objective To analyze the clinical efficacy and safety of intravenous urokinase thrombolysis in myocardial infarction. Methods 62 patients with acute myocardial infarction and in accordance with the conditions of the treatment of thrombolysis thrombolysis and specification. Results 31 cases 6 hours of thrombolysis, 28 cases of dissolution, 3 cases did not pass; the incidence of 6 - 24 hours of thrombolysis in 31 cases, 25 cases of dissolution, 6 cases did not pass; recanalization in 2 patients died because of complications, 3 cases died of undissolved cases. Conclusion intravenous thrombolytic therapy is safe and effective, cheap price, thrombolytic therapy for the key to the treatment of AMI, for clinical application.
